Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA DR. DATSONS LABS AJANTA PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x 27.7 -10.9 - View Chart
P/BV x 6.8 0.2 4,214.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 AJANTA PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
DR. DATSONS LABS
Mar-14
AJANTA PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,422126 1,132.1%   
Low Rs89831 2,904.9%   
Sales per share (Unadj.) Rs233.5133.0 175.6%  
Earnings per share (Unadj.) Rs44.00.2 28,997.8%  
Cash flow per share (Unadj.) Rs52.26.6 789.3%  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.1128.8 198.1%  
Shares outstanding (eoy) m88.0231.66 278.0%   
Bonus/Rights/Conversions BBFCCB-  
Price / Sales ratio x5.00.6 844.1%   
Avg P/E ratio x26.4516.1 5.1%  
P/CF ratio (eoy) x22.211.8 187.8%  
Price / Book Value ratio x4.50.6 748.3%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,0812,477 4,120.5%   
No. of employees `0006.8NA-   
Total wages/salary Rs m4,30756 7,691.3%   
Avg. sales/employee Rs Th3,022.6NM-  
Avg. wages/employee Rs Th633.4NM-  
Avg. net profit/employee Rs Th569.1NM-  
INCOME DATA
Net Sales Rs m20,5544,211 488.2%  
Other income Rs m21179 267.9%   
Total revenues Rs m20,7654,289 484.1%   
Gross profit Rs m5,664569 996.2%  
Depreciation Rs m721204 352.6%   
Interest Rs m12430 2.7%   
Profit before tax Rs m5,14313 40,493.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2736 20,868.9%   
Profit after tax Rs m3,8705 80,618.8%  
Gross profit margin %27.613.5 204.1%  
Effective tax rate %24.848.0 51.5%   
Net profit margin %18.80.1 16,515.0%  
BALANCE SHEET DATA
Current assets Rs m11,8126,852 172.4%   
Current liabilities Rs m3,7766,711 56.3%   
Net working cap to sales %39.13.3 1,167.5%  
Current ratio x3.11.0 306.4%  
Inventory Days Days77161 48.1%  
Debtors Days Days82318 25.6%  
Net fixed assets Rs m14,3983,673 392.0%   
Share capital Rs m175317 55.4%   
"Free" reserves Rs m22,2773,761 592.3%   
Net worth Rs m22,4524,078 550.6%   
Long term debt Rs m71,671 0.4%   
Total assets Rs m26,96212,633 213.4%  
Interest coverage x444.31.0 43,159.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.3 228.7%   
Return on assets %14.43.4 418.1%  
Return on equity %17.20.1 14,641.1%  
Return on capital %23.07.7 299.1%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m10,682964 1,108.1%   
Fx outflow Rs m2,102607 346.2%   
Net fx Rs m8,580357 2,404.0%   
CASH FLOW
From Operations Rs m3,7481,345 278.7%  
From Investments Rs m-2,228-2,256 98.8%  
From Financial Activity Rs m-1,475-1,200 122.9%  
Net Cashflow Rs m45-2,111 -2.1%  

Share Holding

Indian Promoters % 73.8 4.5 1,629.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 0.0 -  
FIIs % 7.6 1.4 563.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 94.1 18.1%  
Shareholders   20,968 20,807 100.8%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 15, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS